Immune checkpoint inhibitors in the treatment of virus-associated cancers
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune checkpoint inhibitors in the treatment of virus-associated cancers
Authors
Keywords
Immunotherapy, Immune checkpoint inhibitors, Virus-associated cancers
Journal
Journal of Hematology & Oncology
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-10
DOI
10.1186/s13045-019-0743-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinicopathological and molecular features of responders to nivolumab for patients with advanced gastric cancer
- (2019) Saori Mishima et al. Journal for ImmunoTherapy of Cancer
- Safety and Efficacy of Immune Checkpoint Inhibitor Therapy in Patients With HIV Infection and Advanced-Stage Cancer
- (2019) Michael R. Cook et al. JAMA Oncology
- The effects of checkpoint inhibition on head and neck squamous cell carcinoma: A systematic review
- (2019) Mustafa Ghanizada et al. ORAL ONCOLOGY
- Immune check-point in cervical cancer
- (2018) F. De Felice et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- PD-1 and PD-L1 expression in HNSCC primary cancer and related lymph node metastasis - impact on clinical outcome
- (2018) Sven Schneider et al. HISTOPATHOLOGY
- Significant association of increased PD-L1 and PD-1 expression with nodal metastasis and a poor prognosis in oral squamous cell carcinoma
- (2018) Y. Maruse et al. INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
- Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
- (2018) Brigette B.Y. Ma et al. JOURNAL OF CLINICAL ONCOLOGY
- Checkpoint inhibitors in head and neck cancer: current knowledge and perspectives
- (2018) Bachar Samra et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
- (2018) Seung Tae Kim et al. NATURE MEDICINE
- Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
- (2018) Robert L. Ferris et al. ORAL ONCOLOGY
- An open-label, multiple ascending dose study of the anti-CTLA-4 antibody ipilimumab in viremic HIV patients
- (2018) Elizabeth Colston et al. PLoS One
- Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments
- (2018) Benjamin Solomon et al. SEMINARS IN CANCER BIOLOGY
- Comparison of Efficacy of Pembrolizumab between Epstein-Barr Virus‒Positive and ‒Negative Relapsed or Refractory Non-Hodgkin Lymphomas
- (2018) Seok-Jin Kim et al. Cancer Research and Treatment
- Immune Checkpoint Inhibitors in the Treatment of Patients with Neuroendocrine Neoplasia
- (2018) Matthias M. Weber et al. Oncology Research and Treatment
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Molecular mechanisms of viral oncogenesis in humans
- (2018) Nathan A. Krump et al. NATURE REVIEWS MICROBIOLOGY
- A Review of HPV-Related Head and Neck Cancer
- (2018) Kazuhiro Kobayashi et al. Journal of Clinical Medicine
- The Human Papillomavirus as a Common Pathogen in Oropharyngeal, Anal and Cervical Cancers
- (2018) S. Otter et al. CLINICAL ONCOLOGY
- Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy
- (2018) Dan P. Zandberg et al. EUROPEAN JOURNAL OF CANCER
- Molecular mechanisms of EBV-driven cell cycle progression and oncogenesis
- (2018) Huali Yin et al. MEDICAL MICROBIOLOGY AND IMMUNOLOGY
- Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1–Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study
- (2017) Chiun Hsu et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1–Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial
- (2017) Jean-Sebastien Frenel et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study
- (2017) Joshua Bauml et al. JOURNAL OF CLINICAL ONCOLOGY
- Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
- (2017) Austin G. Duffy et al. JOURNAL OF HEPATOLOGY
- Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy
- (2017) Cynthia L. Gay et al. JOURNAL OF INFECTIOUS DISEASES
- Expressions of programmed death (PD)-1 and PD-1 ligand (PD-L1) in cervical intraepithelial neoplasia and cervical squamous cell carcinomas are of prognostic value and associated with human papillomavirus status
- (2017) Wen Yang et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study
- (2017) Van K Morris et al. LANCET ONCOLOGY
- Immune Checkpoint Inhibition in Hepatocellular Carcinoma: Basics and Ongoing Clinical Trials
- (2017) Masatoshi Kudo ONCOLOGY
- Epstein–Barr virus-associated lymphomas
- (2017) Claire Shannon-Lowe et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- The Exceptional Oncogenicity of HTLV-1
- (2017) Yutaka Tagaya et al. Frontiers in Microbiology
- Biological Features of Human Papillomavirus-related Head and Neck Cancers Contributing to Improved Response
- (2016) C. Cleary et al. CLINICAL ONCOLOGY
- Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
- (2016) Tanguy Y Seiwert et al. LANCET ONCOLOGY
- Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix
- (2016) A Marijne Heeren et al. MODERN PATHOLOGY
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
- (2016) Robert L. Ferris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Global burden of cancers attributable to infections in 2012: a synthetic analysis
- (2016) Martyn Plummer et al. Lancet Global Health
- Epidemiology of Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma
- (2015) Maura L. Gillison et al. JOURNAL OF CLINICAL ONCOLOGY
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Human Viral Oncogenesis: A Cancer Hallmarks Analysis
- (2014) Enrique A. Mesri et al. Cell Host & Microbe
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- Evidence for a Role of the PD-1:PD-L1 Pathway in Immune Resistance of HPV-Associated Head and Neck Squamous Cell Carcinoma
- (2013) S. Lyford-Pike et al. CANCER RESEARCH
- Hepatocellular Carcinoma from an Immunologic Perspective
- (2013) T. F. Greten et al. CLINICAL CANCER RESEARCH
- Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia
- (2013) Wen Yang et al. IMMUNOLOGY
- A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
- (2013) Bruno Sangro et al. JOURNAL OF HEPATOLOGY
- Alternating chemoradiotherapy in patients with nasopharyngeal cancer: prognostic factors and proposal for individualization of therapy
- (2013) Y. Goto et al. JOURNAL OF RADIATION RESEARCH
- Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels
- (2013) Ahmedin Jemal et al. JNCI-Journal of the National Cancer Institute
- A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus Infection
- (2013) David Gardiner et al. PLoS One
- Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy
- (2012) M. R. Green et al. CLINICAL CANCER RESEARCH
- Comparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma
- (2012) Ying Jin et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- DNA viruses and the cellular DNA-damage response
- (2012) A. S. Turnell et al. JOURNAL OF GENERAL VIROLOGY
- Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
- (2010) K. Kian Ang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of HPV-Associated p16INK4A Expression on Response to Radiotherapy and Survival in Squamous Cell Carcinoma of the Head and Neck
- (2009) Pernille Lassen et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial
- (2008) C. Fakhry et al. JNCI-Journal of the National Cancer Institute
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search